Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
May 12, 2020

Anti-viral nanocoating could prevent surface transmission of SARS-CoV-2

By Chloe Kent

Researchers at Ben-Gurion University of the Negev (BGU) are developing safe, anti-viral nanoparticle coatings to prevent active surface infection of the SARS-CoV-2 virus, which causes Covid-19.

The virus has been shown to live for up to 17 days on surfaces, where it can be contracted if touched by a human being. The nanocoating, if effective, could be used in hospitals, healthcare facilities and public locations to eradicate virus particles that adhere to them.

The coating contains nanoparticles of safe metal ions and polymers, combined with antiviral and antimicrobial properties that could be effective for weeks or even months.

BGU senior lecturer in materials engineering Dr Mark Schvartzman said: “While current surface disinfection methods rely mostly on substances that are poisonous for people, such as bleach, or on substances that evaporate readily being based on alcohol, the coating that we are developing is based on metals that are toxic for viruses or bacteria, but completely human-friendly.”

Related Companies

Content from our partners
Precision wire: The future of bespoke medical treatment
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
“This technique means everything to us”: How CGM devices empower users 

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU